Targeted proteomics dataset (PRM) investigating four potential biomarker candidates of high-grade serous ovarian carcinoma (FGL2, LGALS3BP, LTBP1, TIMP1) and the established biomarker CA125 in 212 serum samples taken from 34 HGSC patients during disease progression.
[doi:10.25345/C5NG4H296]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: targeted proteomics ; parallel reaction monitoring ; PRM ; high-grade serous ovarian carcinoma ; ovarian cancer ; serum biomarker ; surveillance biomarker ; biomarker validation
Principal Investigators: (in alphabetical order) |
Dr. Thomas Kislinger, Princess Margaret Cancer Centre, Canada |
Submitting User: | TKislinger |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | |
FTP Download Link (click to copy):
|